This text is a result of machine translation.
F-star to be acquired by China biopharmaceutical with USD 161million
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
The investment banking business was strictly supervised, and seven securities companies received fines
Cellatopia Secures Nearly CNY Ten Mn in Seed Funding
EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).
Apr 18, 2024 01:25 PM
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
Amazon: the policy is consistent all over the world, and the title is not for Chinese businesses
Zhang Kun's four funds decreased their positions in the second quarter by allocating Wuliangye to Guizhou Maotai
Chinese Cuisine Brand YGF Malatang Ventures into Brazil
Yesterday 02:21 PM